medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 05

<< Back Next >>

Ginecol Obstet Mex 2019; 87 (05)

Treatment of breast cancer in pregnant women: clinical case

Montaño-Serrano M, Rojo-Novo S, Albalat-Fernández R, Novo-Cabrera J, La Calle-Marcos M
Full text How to cite this article

Language: Spanish
References: 22
Page: 324-333
PDF size: 381.72 Kb.


Key words:

Breast cancer, Pregnancy, Radiotherapy, Chemotherapy, Sentinel lymph node biopsy, Mastectomy.

ABSTRACT

Background: Breast cancer is the most prevalent cancer nowadays and is the most common at the pregnancy and postpartum period. The incidence is between 0.2-2.6% and is currently increasing due to delayed childbearing. The treatment implies a challenge for the health systems because the welfare of the mother and her child must be valued and safeguarded.
Clinical case: A 26-year-old patient who attended the consultation for right mastalgia, with rapid growth from the beginning of pregnancy. During the mammary examination, a hard consistency tumor of 8 cm was observed, occupying both upper quadrants of the right breast, with reddening of the skin. The ultrasound revealed a heterogeneous solid-cystic tumor, 8 x 5 cm, without pathological axillary lymph nodes. The anatomopathological study of the biopsy reported an infiltrating carcinoma, with triple negative immunophenotype (negative immunoreactivity for estrogen and progesterone receptors, and Her-2 with Ki67 proliferation index of 80%), which confirmed the diagnosis of breast cancer locally advanced in the second trimester of pregnancy. After administration of three cycles of neoadjuvant chemotherapy with anthracyclines (doxorubicin and cyclophosphamide) trisemanales, termination of pregnancy was indicated by induction of labor at week 36 + 6. A male was born at 2800 g, with Apgar 9-10- 10 The mother and her son evolved satisfactorily, so they were discharged 4 days after the intervention. Ten months after mastectomy, she enjoys good physical and psycho-logical health, as does her 15-month-old son. Continues in close monitoring in the Oncology service.
Conclusions: The treatment of breast cancer during pregnancy is safe and offers good long-term results. The important intervention and multidisciplinary assessment, in addition to the correct advice and psychological support to the family.


REFERENCES

  1. Álvarez-Tapias C, et al. Actualización del manejo clínico del cáncer mamario asociado al embarazo. Revisión de la Literatura. Rev Colomb Salud Libre 2017;(2):50-59. http:// doi.org/10.1016/j.rccan.2017.02.018

  2. Shim M, et al. Clinical characteristics and outcome of cancer diagnosed during pregnancy. Obstet Gynecol Sci. 2016;59(1):1-8. http://doi.org/10.5468/ogs.2016.59.1.1

  3. Shlensky V, et al. Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines?. Am J Perinatol Rep. 2017;7(1):39-43. http://doi. org/10.1055/s-0037-1599133

  4. Sule E, et al. Management of pregnancy associated breast cancer with chemotherapy in a developing country. Int J Surg Case Rep 2015;17:117-120. http://doi.org/10.1016/j. ijscr.2015.10.008

  5. Albalat-Fernández R, et al. Biopsia selectiva de ganglio centinela en mujer embarazada con cáncer de mama. Prog Obstet Ginecol. 2015;58(6):283-286. http://doi. org/10.1016/j.pog.2015.02.008

  6. Hernández-Blanquisett A, et al. Breast cancer in pregnancy: an institutional experience. Ecancermedicalscience. 2015;9:551. http://doi.org/10.3332/ecancer.2015.551

  7. Rovera F, et al. Breast cancer in pregnancy. Breast J 2010;16(Suppl 1):S22-5. http://doi.org/10.1111/j.1524- 4741.2010.00998.x

  8. Simonescu A, et al. Advanced metastatic breast cancer in pregnancy: the imperative of physical breast examination in pregnancy. Rom J Morphol Embryol 2017;58(2):645-650. http:// www.rjme.ro/RJME/resources/files/580217645650.pdf

  9. Upadhayay R, et al. Triple negative breast cancer in pregnancy and postpartum: two case reports in hispanic women. Case Rep Obstet Gynecol 2015;2015:856931. http:// doi.org/10.1155/2015/856931

  10. Zagouri F, et al. Cancer in pregnancy: disentangling treatment modalities. ESMO Open. 2016;1(3):e000016. http://doi.org/10.1136/esmoopen-2015-000016

  11. Ye X, et al. Study on the adverse effects following chemotherapy for breast cancer diagnosis during pregnancy. Medicine 2017;96(46):e8582. http://doi.org/10.1097/ MD.0000000000008582

  12. Nargotra N, et al. Pregnancy associated breast cancer: awareness is the key to diagnosis-a case report. J Clin Diagn Res 2015;9(11):9-11. http://doi.org/10.7860/ JCDR/2015/15022.6832

  13. International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000;30(1):iii-viii, 1-43.

  14. DeSantis CE, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64(4):252-71. http:// doi.org/10.3322/caac.21235

  15. Amant F, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. The Lancet Oncology, 2012; 13(3):256-264. http://doi.org/10.1016/ S1470-2045(11)70363-1

  16. Litton JK, et al. Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist 2010;15(12):1238- 47. http://doi.org/10.1634/theoncologist.2010-0262

  17. Peccatori F, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;(Suppl 6):160-70. http://doi. org/10.1093/annonc/mdt199

  18. Calsteren KV, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer 2010;20:1456-64. http://doi. org/10.1111/IGC.0b013e3181fb18c8

  19. Loibl S, et al. Treatment of breast cancer during pregnancy: an observational study. The Lancet Oncology 2012;13(9):887- 896. http://doi.org/10.1016/S1470-2045(12)70261-9

  20. Zagouri F, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat 2013;137:349-57. http://doi.org/10.1007/ s10549-012-2368-y

  21. Amant F, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013;31(20):2532- 2539. http://doi.org/10.1200/JCO.2012.45.6335

  22. Gentilini O, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-51. http://doi.org/10.1093/annonc/mdh355




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2019;87